The DOI matches its Crossref record; 136 of the 136 references it cites were found in a registry or an index.
Fibrosis: Types, Effects, Markers, Mechanisms for Disease Progression, and Its Relation with Oxidative Stress, Immunity, and Inflammation
Open accessAbstract
Most chronic inflammatory illnesses include fibrosis as a pathogenic characteristic. Extracellular matrix (ECM) components build up in excess to cause fibrosis or scarring. The fibrotic process finally results in organ malfunction and death if it is severely progressive. Fibrosis affects nearly all tissues of the body. The fibrosis process is associated with chronic inflammation, metabolic homeostasis, and transforming growth factor-β1 (TGF-β1) signaling, where the balance between the oxidant and antioxidant systems appears to be a key modulator in managing these processes. Virtually every organ system, including the lungs, heart, kidney, and liver, can be affected by fibrosis, which is characterized as an excessive accumulation of connective tissue components. Organ malfunction is frequently caused by fibrotic tissue remodeling, which is also frequently linked to high morbidity and mortality. Up to 45% of all fatalities in the industrialized world are caused by fibrosis, which can damage any organ. Long believed to be persistently progressing and irreversible, fibrosis has now been revealed to be a very dynamic process by preclinical models and clinical studies in a variety of organ systems. The pathways from tissue damage to inflammation, fibrosis, and/or malfunction are the main topics of this review. Furthermore, the fibrosis of different organs with their effects was discussed. Finally, we highlight many of the principal mechanisms of fibrosis. These pathways could be considered as promising targets for the development of potential therapies for a variety of important human diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reactive oxygen species (ROS) as pleiotropic physiological signalling agents
Sies, H., & Jones, D. P. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0230-3 · Cited by 5,335
Frangogiannis, N. G. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvaa324 · Cited by 1,229 · cited 1×
“Cardiac fibrosis is an aberrant thickening of the heart valves caused by unsuitable fibroblast proliferation, but it is more frequently used to describe the excessive deposition of ECM in the cardiac muscle, as described in Figure 12 [123].”
BackgroundNew insights into TGF-β/Smad signaling in tissue fibrosis
Hu, H.-H., Chen, D.-Q., Wang, Y.-N., Feng, Y.-L., Cao, G., Vaziri, N. D., & Zhao, Y.-Y. (2018) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2018.07.008 · Cited by 1,179
Targeting TGF-β signal transduction for fibrosis and cancer therapy
Peng, D., Fu, M., Wang, M., Wei, Y., & Wei, X. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01569-x · Cited by 1,065
Oxidative stress in health and disease: The therapeutic potential of Nrf2 activation
Hybertson, B. M., Gao, B., Bose, S. K., & McCord, J. M. (2011) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2011.10.006 · Cited by 1,015
Reversal of persistent fibrosis in aging by targeting Nox4-Nrf2 redox imbalance
Hecker, L., Logsdon, N. J., Kurundkar, D., Kurundkar, A., Bernard, K., Hock, T., Meldrum, E., Sanders, Y. Y., & Thannickal, V. J. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008182 · Cited by 686 · cited 1×
“Studies have shown that bleomycin-induced fibrosis in mice can be prevented by genetically impairing NOX4 or by pharmacologically inhibiting it [58].”
BackgroundAntioxidant Defence Systems and Oxidative Stress in Poultry Biology: An Update
Surai, P. F., Kochish, I. I., Fisinin, V. I., & Kidd, M. T. (2019) · Antioxidants · doi:10.3390/antiox8070235 · Cited by 655
Diverse Roles of TGF-β/Smads in Renal Fibrosis and Inflammation
Lan, H. Y. (2011) · International Journal of Biological Sciences · doi:10.7150/ijbs.7.1056 · Cited by 652
Shared and distinct mechanisms of fibrosis
Distler, J. H. W., Györfi, A.-H., Ramanujam, M., Whitfield, M. L., Königshoff, M., & Lafyatis, R. (2019) · Nature Reviews Rheumatology · doi:10.1038/s41584-019-0322-7 · Cited by 637
Transforming growth factor beta (TGF‐β) isoforms in wound healing and fibrosis
Lichtman, M. K., Otero‐Vinas, M., & Falanga, V. (2016) · Wound Repair and Regeneration · doi:10.1111/wrr.12398 · Cited by 626
Targeting fibrosis: mechanisms and clinical trials
Zhao, M., Wang, L., Wang, M., Zhou, S., Lu, Y., Cui, H., Racanelli, A. C., Zhang, L., Ye, T., Ding, B., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01070-3 · Cited by 547
NF-κB: blending metabolism, immunity, and inflammation
Capece, D., Verzella, D., Flati, I., Arboretto, P., Cornice, J., & Franzoso, G. (2022) · Trends in Immunology · doi:10.1016/j.it.2022.07.004 · Cited by 538 · cited 1×
“NF-κB is a crucial transcription factor in the regulation of inflammation, the immune system, and cancer [87].”
BackgroundOxidative stress and pulmonary fibrosis
Cheresh, P., Kim, S.-J., Tulasiram, S., & Kamp, D. W. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.11.021 · Cited by 530
Bleomycin in the setting of lung fibrosis induction: From biological mechanisms to counteractions
Della Latta, V., Cecchettini, A., Del Ry, S., & Morales, M. A. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.04.012 · Cited by 514
Kapoor, D., Singh, S., Kumar, V., Romero, R., Prasad, R., & Singh, J. (2019) · Plant Gene · doi:10.1016/j.plgene.2019.100182 · Cited by 506
Antioxidant Therapy: Current Status and Future Prospects
Firuzi, O., Miri, R., Tavakkoli, M., & Saso, L. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711803414368 · Cited by 468
TGF-β1 – A truly transforming growth factor in fibrosis and immunity
Lodyga, M., & Hinz, B. (2020) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2019.12.010 · Cited by 458
Metabolic Messengers: tumour necrosis factor
Sethi, J. K., & Hotamisligil, G. S. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00470-z · Cited by 419
Transforming growth factor‐β in stem cells and tissue homeostasis
Xu, X., Zheng, L., Yuan, Q., Zhen, G., Crane, J. L., Zhou, X., & Cao, X. (2018) · Bone Research · doi:10.1038/s41413-017-0005-4 · Cited by 414 · cited 1×
“TGF-β1 is a multifunctional regulator that affects a wide range of basic biological processes, such as cell division, proliferation, and apoptosis, as well as embryonic development and tissue homeostasis [8].”
BackgroundRole of Cardiac Macrophages on Cardiac Inflammation, Fibrosis and Tissue Repair
Lafuse, W. P., Wozniak, D. J., & Rajaram, M. V. S. (2020) · Cells · doi:10.3390/cells10010051 · Cited by 401
Baird, L., Llères, D., Swift, S., & Dinkova-Kostova, A. T. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1305687110 · Cited by 380
Skeletal muscle fibrosis: an overview
Mahdy, M. A. A. (2019) · Cell and Tissue Research · doi:10.1007/s00441-018-2955-2 · Cited by 363
Chen, L., Yang, T., Lu, D.-W., Zhao, H., Feng, Y.-L., Chen, H., Chen, D.-Q., Vaziri, N. D., & Zhao, Y.-Y. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.02.090 · Cited by 359
Emerging cellular and molecular determinants of idiopathic pulmonary fibrosis
Phan, T. H. G., Paliogiannis, P., Nasrallah, G. K., Giordo, R., Eid, A. H., Fois, A. G., Zinellu, A., Mangoni, A. A., & Pintus, G. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03693-7 · Cited by 351
Ma, C. S., Suryani, S., Avery, D. T., Chan, A., Nanan, R., Santner‐Nanan, B., Deenick, E. K., & Tangye, S. G. (2009) · Immunology & Cell Biology · doi:10.1038/icb.2009.64 · Cited by 343
T Cells in Fibrosis and Fibrotic Diseases
Zhang, M., & Zhang, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01142 · Cited by 330
Reactive oxygen species and fibrosis: further evidence of a significant liaison
Richter, K., & Kietzmann, T. (2016) · Cell and Tissue Research · doi:10.1007/s00441-016-2445-3 · Cited by 322
Cardiovascular Aging and Heart Failure
Triposkiadis, F., Xanthopoulos, A., & Butler, J. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.06.053 · Cited by 288
Role of PI3K/Akt signaling pathway in cardiac fibrosis
Qin, W., Cao, L., & Massey, I. Y. (2021) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-021-04219-w · Cited by 277
Yue, Y., Meng, K., Pu, Y., & Zhang, X. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.08.018 · Cited by 240
Chen, T., Zhang, X., Zhu, G., Liu, H., Chen, J., Wang, Y., & He, X. (2020) · Medicine · doi:10.1097/md.0000000000022241 · Cited by 239
The JNK Signaling Pathway in Renal Fibrosis
Grynberg, K., Ma, F. Y., & Nikolic-Paterson, D. J. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00829 · Cited by 223
Liu, J.-R., Miao, H., Deng, D.-Q., Vaziri, N. D., Li, P., & Zhao, Y.-Y. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03645-1 · Cited by 214
Gao, J., Peng, S., Shan, X., Deng, G., Shen, L., Sun, J., Jiang, C., Yang, X., Chang, Z., Sun, X., et al. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-2195-8 · Cited by 192
Targeting the renin-angiotensin-aldosterone system in fibrosis
AlQudah, M., Hale, T. M., & Czubryt, M. P. (2020) · Matrix Biology · doi:10.1016/j.matbio.2020.04.005 · Cited by 191
Wnt signaling pathway in aging-related tissue fibrosis and therapies
Hu, H.-H., Cao, G., Wu, X.-Q., Vaziri, N. D., & Zhao, Y.-Y. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101063 · Cited by 190
Mu, M., Zuo, S., Wu, R.-M., Deng, K.-S., Lu, S., Zhu, J.-J., Zou, G.-L., Yang, J., Cheng, M.-L., & Zhao, X.-K. (2018) · Drug Design, Development and Therapy · doi:10.2147/dddt.s186726 · Cited by 186
Therapeutic Targets for the Treatment of Cardiac Fibrosis and Cancer: Focusing on TGF-β Signaling
Parichatikanond, W., Luangmonkong, T., Mangmool, S., & Kurose, H. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.00034 · Cited by 173
The inflammatory speech of fibroblasts
Schuster, R., Rockel, J. S., Kapoor, M., & Hinz, B. (2021) · Immunological Reviews · doi:10.1111/imr.12971 · Cited by 172
TGF-β–induced epigenetic deregulation of SOCS3 facilitates STAT3 signaling to promote fibrosis
Dees, C., Pötter, S., Zhang, Y., Bergmann, C., Zhou, X., Luber, M., Wohlfahrt, T., Karouzakis, E., Ramming, A., Gelse, K., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci122462 · Cited by 171
Boyer-Diaz, Z., Aristu-Zabalza, P., Andrés-Rozas, M., Robert, C., Ortega-Ribera, M., Fernández-Iglesias, A., Broqua, P., Junien, J.-L., Wettstein, G., Bosch, J., et al. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2020.11.045 · Cited by 168
TGF-β/SMAD signaling regulation of mesenchymal stem cells in adipocyte commitment
Li, S.-N., & Wu, J.-F. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-1552-y · Cited by 163
Antioxidants as Potential Therapeutics for Lung Fibrosis
Day, B. J. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1916 · Cited by 153
Tuleta, I., & Frangogiannis, N. G. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113904 · Cited by 150
Alunno, A., Padjen, I., Fanouriakis, A., & Boumpas, D. T. (2019) · Cells · doi:10.3390/cells8080898 · Cited by 148
Regulation of cellular senescence by extracellular matrix during chronic fibrotic diseases
Blokland, K. E. C., Pouwels, S. D., Schuliga, M. J., Knight, D. A., & Burgess, J. K. (2020) · Clinical Science · doi:10.1042/cs20190893 · Cited by 147
T Lymphocyte-Mediated Liver Immunopathology of Schistosomiasis
Zheng, B., Zhang, J., Chen, H., Nie, H., Miller, H. E., Gong, Q., & Liu, C. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00061 · Cited by 144
Targeting Oxidative Stress as a Therapeutic Approach for Idiopathic Pulmonary Fibrosis
Estornut, C., Milara, J., Bayarri, M. A., Belhadj, N., & Cortijo, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.794997 · Cited by 143
Kaivo-Oja, N., Jeffery, L. A., Ritvos, O., & Mottershead, D. G. (2006) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-4-21 · Cited by 141
On the Clinical Pharmacology of Reactive Oxygen Species
Casas, A. I., Nogales, C., Mucke, H. A., Petraina, A., Cuadrado, A., Rojo, A. I., Ghezzi, P., Jaquet, V., Augsburger, F., Dufrasne, F., et al. (2020) · Pharmacological Reviews · doi:10.1124/pr.120.019422 · Cited by 140
CTGF in kidney fibrosis and glomerulonephritis
Toda, N., Mukoyama, M., Yanagita, M., & Yokoi, H. (2018) · Inflammation and Regeneration · doi:10.1186/s41232-018-0070-0 · Cited by 132
Bardoxolone ameliorates TGF-β1-associated renal fibrosis through Nrf2/Smad7 elevation
Song, M., Lee, J., Ryoo, I.-G., Lee, S.-H., Ku, S., & Kwak, M. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.04.033 · Cited by 129
Transcriptional Effects of Ozone and Impact on Airway Inflammation
Mumby, S. E., Chung, K. F., & Adcock, I. M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01610 · Cited by 129
Novel mechanisms and clinical trial endpoints in intestinal fibrosis*
Wang, J., Lin, S., Brown, J. M., Wagoner, D. R. V., Fiocchi, C., & Rieder, F. (2021) · Immunological Reviews · doi:10.1111/imr.12974 · Cited by 127
TGF-β/Smad Signaling Pathway in Tubulointerstitial Fibrosis
Yu, X.-Y., Sun, Q., Zhang, Y., Zou, L., & Zhao, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.860588 · Cited by 125
NUAK1 promotes organ fibrosis via YAP and TGF-β/SMAD signaling
Zhang, T., He, X., Caldwell, L., Goru, S. K., Severino, L. U., Tolosa, M. F., Misra, P. S., McEvoy, C. M., Christova, T. Y., Liu, Y., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.aaz4028 · Cited by 123
T follicular helper–like cells contribute to skin fibrosis
Taylor, D. K., Mittereder, N., Kuta, E. G., Delaney, T. A., Burwell, T. J., Dacosta, K., Zhao, W., Cheng, L., Brown, C., Boutrin, A., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf5307 · Cited by 122
Nuclear and Cytoplasmic Functions of Vitamin C
Zhitkovich, A. (2020) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.0c00348 · Cited by 119
Connective-Tissue Growth Factor Contributes to TGF-β1–induced Lung Fibrosis
Yanagihara, T., Tsubouchi, K., Gholiof, M., Chong, S. G., Lipson, K. E., Zhou, Q., Scallan, C. J., Upagupta, C., Tikkanen, J., Keshavjee, S., et al. (2021) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2020-0504oc · Cited by 118
Natural and synthetic compounds in Ovarian Cancer: A focus on NRF2/KEAP1 pathway
Tossetta, G., & Marzioni, D. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106365 · Cited by 115
Antioxidant Enzymes and their Role in Preventing Cell Damage
Bratovčić, A. (2020) · Acta Scientifci Nutritional Health · doi:10.31080/asnh.2020.04.0659 · Cited by 104
SIRT1 as a Therapeutic Target in Diabetic Complications
Strycharz, J., Rygielska, Z., Świderska, E., Drzewoski, J., Szemraj, J., Szmigiero, L., & Śliwińska, A. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867324666171107103114 · Cited by 97
Engineered Biomaterial Platforms to Study Fibrosis
Davidson, M. D., Burdick, J. A., & Wells, R. G. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.201901682 · Cited by 97
Superoxide dismutases: a physiopharmacological update
Valdivia, A., Perez‐Alvarez, S., Aroca‐Aguilar, J., Ikuta, I., & Jordán, J. (2009) · Journal of Physiology and Biochemistry · doi:10.1007/bf03179070 · Cited by 93
Hosseinzadeh, A., Javad-Moosavi, S. A., Reiter, R. J., Yarahmadi, R., Ghaznavi, H., & Mehrzadi, S. (2018) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2018.1541318 · Cited by 92
Forcina, L., Miano, C., Scicchitano, B. M., & Musarò, A. (2019) · Cells · doi:10.3390/cells8030232 · Cited by 90
Liu, J., Kong, D., Qiu, J., Xie, Y., Lu, Z., Zhou, C., Liu, X., Zhang, R., & Wang, Y. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14831 · Cited by 90
Toll-like receptor-induced cytokines as immunotherapeutic targets in cancers and autoimmune diseases
Patra, M. C., Shah, M., & Choi, S. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.05.002 · Cited by 88
T Cells and Acute Kidney Injury: A Two-Way Relationship
Dellepiane, S., Leventhal, J. S., & Cravedi, P. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01546 · Cited by 85
Chen, R.-R., Fan, X., Chen, G., Zeng, G., Xue, Y., Liu, X., & Wang, C. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.01.031 · Cited by 84
Clinkenbeard, E. L., Noonan, M. L., Thomas, J. C., Ni, P., Hum, J. M., Aref, M. W., Swallow, E. A., Moe, S. M., Allen, M. R., & White, K. E. (2019) · JCI Insight · doi:10.1172/jci.insight.123817 · Cited by 82
Dysregulated signalling pathways in innate immune cells with cystic fibrosis mutations
Reyna, S. J. L., Holbrook, J. A., Jarosz-Griffiths, H., Peckham, D. G., & McDermott, M. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03540-9 · Cited by 81
Murata, H., Khine, C. C., Nishikawa, A., Yamamoto, K.-I., Kinoshita, R., & Sakaguchi, M. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.004578 · Cited by 80
Zhu, Z., Hu, R., Li, J., Xing, X., Chen, J., Zhou, Q. X., & Sun, J. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107660 · Cited by 80
Antar, S. A., Abdo, W. S., Taha, R. S., Farage, A. E., EI-Moselhy, L. E., Amer, M. E., Monsef, A. S. A., Hamid, A. M. A., Kamel, E. M., Ahmeda, A. F., et al. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.120260 · Cited by 78
Self-citationValle-Tenney, R., Rebolledo, D. L., Lipson, K. E., & Brandan, E. (2019) · Matrix Biology · doi:10.1016/j.matbio.2019.09.003 · Cited by 74
The role of Wnt signaling in skin fibrosis
Griffin, M., Huber, J., Fahy, E. J., Quarto, N., & Longaker, M. T. (2021) · Medicinal Research Reviews · doi:10.1002/med.21853 · Cited by 73
Fibrotic Idiopathic Interstitial Lung Disease: The Molecular and Cellular Key Players
Samarelli, A. V., Tonelli, R., Marchioni, A., Bruzzi, G., Gozzi, F., Andrisani, D., Castaniere, I., Manicardi, L., Moretti, A., Tabbì, L., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168952 · Cited by 72
Zhang, Z., Li, M., Liu, D., Chen, H., Chen, D., Tan, N., Ma, S., & Zhao, Y. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01029 · Cited by 71
Role of fibroblast growth factor 23 and klotho cross talk in idiopathic pulmonary fibrosis
Barnes, J. W., Duncan, D., Helton, S., Hutcheson, S. B., Kurundkar, D., Logsdon, N. J., Locy, M. L., Garth, J. M., Denson, R. S., Farver, C. F., et al. (2019) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00246.2018 · Cited by 71
NADPH oxidases: Pathophysiology and therapeutic potential in age-associated pulmonary fibrosis
Kato, K., & Hecker, L. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101541 · Cited by 70
Toward improved human health: efficacy of dietary selenium on immunity at the cellular level
Xia, X., Zhang, X., Liu, M., Duan, M., Zhang, S., Wei, X., & Liu, X. (2020) · Food & Function · doi:10.1039/d0fo03067h · Cited by 69
Liaskou, E., Patel, S. R., Webb, G. J., Dimakou, D. B., Akiror, S., Krishna, M., Mells, G. F., Jones, D. E., Bowman, S., Barone, F., et al. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.07.020 · Cited by 68
Innate Immunity in Systemic Sclerosis Fibrosis: Recent Advances
Laurent, P., Sisirak, V., Lazaro, E., Richez, C., Duffau, P., Blanco, P., Truchetet, M., & Contin‐Bordes, C. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01702 · Cited by 64
Targeting monocytes/macrophages in fibrosis and cancer diseases: Therapeutic approaches
Conte, E. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.108031 · Cited by 64
Daněk, P., Adamcova, M. K., Janečková, L., Karkoulia, E., Vanickova, K., Fabišik, M., Lozano-Asencio, C., Benoukraf, T., Tirado-Magallanes, R., Zhou, Q., et al. (2020) · Blood · doi:10.1182/blood.2019004664 · Cited by 63
Vitamin E and Non-Communicable Diseases: A Review
Ciarcià, G., Bianchi, S., Tomasello, B., Acquaviva, R., Malfa, G. A., Николаевна, Н. И., Mantia, A. L., & Giacomo, C. D. (2022) · Biomedicines · doi:10.3390/biomedicines10102473 · Cited by 63
The Role of Macrophages in Liver Fibrosis: New Therapeutic Opportunities
Binatti, E., Gerussi, A., Barisani, D., & Invernizzi, P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126649 · Cited by 62
Kaasbøll, O. J., Gadicherla, A. K., Wang, J., Monsen, V. T., Hagelin, E. M. V., Dong, M., & Attramadal, H. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.004559 · Cited by 61
Menshikh, A., Scarfe, L., Delgado, R., Finney, C., Zhu, Y., Yang, H., & de Caestecker, M. P. (2019) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00366.2019 · Cited by 61
Schnieder, J., Mamazhakypov, A., Birnhuber, A., Wilhelm, J., Kwapiszewska, G., Ruppert, C., Markart, P., Wujak, L. A., Rubio, K., Barreto, G., et al. (2019) · Matrix Biology · doi:10.1016/j.matbio.2019.12.001 · Cited by 58
Lee, C., Kim, M.-J., Han, J., Yoon, M. H., & Jung, Y. (2021) · Biomedicines · doi:10.3390/biomedicines9111598 · Cited by 58
Dong, J., & Ma, Q. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01140 · Cited by 55
WNT Signaling in Hematological Malignancies
Frenquelli, M., & Tonon, G. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.615190 · Cited by 55
Meng, Q., Bhandary, B., Bhuiyan, M. S., James, J., Osińska, H. E., Valiente-Alandí, Í., Shay‐Winkler, K., Gulick, J. M., Molkentin, J. D., Blaxall, B. C., et al. (2018) · Circulation Research · doi:10.1161/circresaha.118.313089 · Cited by 53
Understanding relaxin signalling at the cellular level
Valkovic, A. L., Bathgate, R. A. D., Samuel, C. S., & Kočan, M. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2018.12.017 · Cited by 53
NRF2 modulation in TRAMP mice: an in vivo model of prostate cancer
Marzioni, D., Roberta Mazzucchelli, A., Fantone, S., & Tossetta, G. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-08052-2 · Cited by 50
The role of macrophage-derived TGF-β1 on SiO 2 -induced pulmonary fibrosis: A review
Zhang, Z., Tian, H.-T., Hu, L., & Xie, R. (2021) · Toxicology and Industrial Health · doi:10.1177/0748233721989896 · Cited by 49
Mansour, D. F., Saleh, D. O., Ahmed-Farid, O. A.-H., Rady, M., Bakeer, R. M., & Hashad, I. M. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112201 · Cited by 47
Chang, C., Lin, C., Lee, C., Chuang, H., Shih, F.-C., Wan, S.-W., Tai, C., & Chen, C. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114356 · Cited by 46
Busilacchi, E. M., Costantini, A., Mancini, G., Tossetta, G., Olivieri, J., Poloni, A., Viola, N., Butini, L., Campanati, A., Goteri, G., et al. (2020) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2020.01.014 · Cited by 45
Methatham, T., Tomida, S., Kimura, N., Imai, Y., & Aizawa, K. (2021) · Scientific Reports · doi:10.1038/s41598-021-94169-6 · Cited by 44
How Acute Kidney Injury Contributes to Renal Fibrosis
Yang, L. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-8871-2_7 · Cited by 41
CXCL10-induced IL-9 promotes liver fibrosis via Raf/MEK/ERK signaling pathway
Guo, X., Cen, Y., Wang, J., & Jiang, H.-X. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.05.128 · Cited by 39
Kunimi, H., Miwa, Y., Inoue, H., Tsubota, K., & Kurihara, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133171 · Cited by 38
Efficacy of antioxidant in idiopathic pulmonary fibrosis: A systematic review and meta-analysis
Kandhare, A. D., Mukherjee-Kandhare, A. A., Ghosh, P., & Bodhankar, S. L. (2016) · EXCLI journal · doi:10.17179/excli2016-619 · Cited by 37
Goteri, G., Altobelli, E., Tossetta, G., Zizzi, A., Avellini, C., Licini, C., Lorenzi, T., Castellucci, M., Ciavattini, A., & Marzioni, D. (2015) · European Journal of Histochemistry · doi:10.4081/ejh.2015.2570 · Cited by 36
Zou, M., Zou, J., Hu, X., Zheng, W., Zhang, M., & Cheng, Z. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.788714 · Cited by 36
Jiang, M., Fan, J., Qu, X., Li, S., Nilsson, S. K., Sun, Y., Chen, Y., Yu, D., Liu, D., Liu, B., et al. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00880 · Cited by 34
Diao, W., Chen, W., Cao, W., Yuan, H., Ji, H., Wang, T., Chen, W., Zhu, X., Zhou, H. Y., Guo, H., et al. (2019) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2019.05.020 · Cited by 33
Saleh, M. A., Antar, S. A., Hazem, R. M., & El-Azab, M. F. (2020) · Pharmaceuticals · doi:10.3390/ph13110348 · Cited by 33
Self-citationDeleterious Role of Th9 Cells in Pulmonary Fibrosis
Deng, K., Yang, X. S., Luo, Q., She, Y. X., Yu, Q. Y., & Tang, X. X. (2021) · Cells · doi:10.3390/cells10113209 · Cited by 33
The Mechanism of CD8+ T Cells for Reducing Myofibroblasts Accumulation during Renal Fibrosis
Gao, M., Wang, J., Zang, J., An, Y., & Dong, Y. (2021) · Biomolecules · doi:10.3390/biom11070990 · Cited by 32
Palka, J. A., Ościłowska, I., & Szoka, Ł. (2021) · Amino Acids · doi:10.1007/s00726-021-02968-y · Cited by 29
Meirelles, L. D. S., Marson, R. F., Solari, M. I. G., & Nardi, N. B. (2020) · Cells · doi:10.3390/cells9010188 · Cited by 27
Zhang, Y., Shen, L., Dreißigacker, K., Zhu, H., Trinh‐Minh, T., Meng, X., Manh, C. T., Dees, C., Matei, A., Chen, C., et al. (2021) · Blood · doi:10.1182/blood.2020008720 · Cited by 27
Jiang, Z., Bian, M., Wu, J., Li, D., Ding, L., & Zeng, Q. (2020) · BioMed Research International · doi:10.1155/2020/5939815 · Cited by 25
Advances in the clinical use of collagen as biomarker of liver fibrosis
Meurer, S. K., Karsdal, M. A., & Weiskirchen, R. (2020) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2020.1814746 · Cited by 25
Antar, S. A., El-Gammal, M. A., Hazem, R. M., & Moustafa, Y. M. (2022) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-18401-6 · Cited by 25
Self-citationTieyuan, Z., Zhang, Y., Xinghua, Z., Huimin, W., & Huagang, L. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109107 · Cited by 25
Targeting Canonical and Non-Canonical STAT Signaling Pathways in Renal Diseases
Gai, L., Zhu, Y., Zhang, C., & Meng, X. (2021) · Cells · doi:10.3390/cells10071610 · Cited by 24
Expression of genes involved in the NF-κB-dependent pathway of the fibrosis in the mare endometrium
Domino, M., Jasiński, T., Kautz, E., Juszczuk‐Kubiak, E., Ferreira-Dias, G. M., Zabielski, R., Sady, M., & Gajewski, Z. (2020) · Theriogenology · doi:10.1016/j.theriogenology.2020.01.055 · Cited by 23
ElMahdy, M. K., Antar, S. A., Elmahallawy, E. K., Abdo, W. S., Hijazy, H. H. A., Albrakati, A., & Khodir, A. E. (2021) · Biomedicines · doi:10.3390/biomedicines10010040 · Cited by 22
Self-citationAntar, S. A., Al-Karmalawy, A. A., Mourad, A., Mourad, M., Elbadry, M., Saber, S., & Khodir, A. E. (2022) · Pharmaceutical Sciences · doi:10.34172/ps.2022.4 · Cited by 22
Self-citationNew concepts in regulation and function of the FGF23
Dastghaib, S., Koohpeyma, F., Shams, M., Saki, F., & Alizadeh, A. A. (2022) · Clinical and Experimental Medicine · doi:10.1007/s10238-022-00844-x · Cited by 21
Long, Y., Zhao, X. T., Liu, C., Liu, C., & Liu, C. (2020) · Clinical & Experimental Immunology · doi:10.1111/cei.13485 · Cited by 16
Li, D., Ma, D., Liu, Y., Liu, L., Chen, Y., Liu, H., Zhang, L., Lu, J., Chen, K., You, J., et al. (2022) · Folia Histochemica et Cytobiologica · doi:10.5603/fhc.a2022.0011 · Cited by 15
Coeyman, S. J., Richardson, W. J., & Bradshaw, A. D. (2022) · Current Opinion in Physiology · doi:10.1016/j.cophys.2022.100560 · Cited by 15
Geng, C., Wei, J., & Wu, C. (2019) · Neurochemical Research · doi:10.1007/s11064-019-02791-8 · Cited by 12
Canadian Contributions in Fibroblast Biology
Al‐Hattab, D. S., Chattopadhyaya, S., & Czubryt, M. P. (2022) · Cells · doi:10.3390/cells11152272 · Cited by 10
Qing, Z., Yuan, W., Wang, J., Song, W., Luo, J., Wu, X., Lu, Q., Li, Y., & Zeng, M. (2022) · International Urology and Nephrology · doi:10.1007/s11255-022-03284-4 · Cited by 10
MiRNA-Mediated Fibrosis in the Out-of-Target Heart following Partial-Body Irradiation
Tanno, B., Novelli, F., Leonardi, S., Merla, C., Babini, G., Giardullo, P., Kadhim, M. A., Traynor, D., Medipally, D., Meade, A. D., et al. (2022) · Cancers · doi:10.3390/cancers14143463 · Cited by 8
Kamel, A. K. A., Hozayen, W. G., Abdel-Kawi, S. H., & Hashem, K. S. (2021) · Biological Trace Element Research · doi:10.1007/s12011-021-02913-w · Cited by 5
JUN Amino Terminal Kinase in Cell Death and Inflammation in Acute and Chronic Kidney Disease
Nikolic‐Paterson, D. J., Grynberg, K., & Ma, F. Y. (2021) · Integrative Medicine in Nephrology and Andrology · doi:10.4103/imna.imna_35_21 · Cited by 5
Lee, J., Ko, J., Kim, H., Im, H., Kim, E. J., & Yi, J. Y. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.10.095 · Cited by 3
Effects of FGF23 in the distal nephron
Erben, R. G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818036-5.00021-5 · Cited by 1
Cited by
Antar, S. A., Ashour, N. A., Sharaky, M., Khattab, M., Ashour, N. A., Zaid, R. T., Roh, E. J., Elkamhawy, A., & Al-Karmalawy, A. A. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115734 · Cited by 622
Self-citationMechanotransductive receptor Piezo1 as a promising target in the treatment of fibrosis diseases
Xu, Y., Huang, Y., Cheng, X., Hu, B., Jiang, D., Wu, L., Peng, S., & Hu, J. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1270979 · Cited by 24
Targeting interleukin-17 as a novel treatment option for fibrotic diseases
Sisto, M., & Lisi, S. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm13010164 · Cited by 22
Mills, M., Emori, C., Kumar, P., Boucher, Z., George, J., & Bolcun-Filas, E. (2025) · Developmental Biology · doi:10.1016/j.ydbio.2024.09.007 · Cited by 12
Balan, O. V., Malysheva, I. E., & Fedorenko, O. M. (2025) · Russian Journal of Genetics · doi:10.1134/s1022795424701643 · Cited by 1
Metadata
- Authors
- Antar, S. A., Ashour, N. A., Marawan, M. E., & Al-Karmalawy, A. A.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2023-02-16
- Volume
- 24
- Issue
- 4
- Pages
- 4004
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W4321242142
- Cited by
- 366
- References
- 136
- FWCI
- 58.14
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.